Phosphorothioate Oligodeoxynucleotides Bind to Basic Fibroblast Growth Factor, Inhibit Its Binding to Cell Surface Receptors, and Remove It from Low Affinity Binding Sites on Extracellular Matrix

This publication has 28 references indexed in Scilit:

• Suramin, an Active Drug for Prostate Cancer: Interim Observations in a Phase I Trial
  JNCI Journal of the National Cancer Institute, 1993
• Inhibition by Pentosan Polysulfate (PPS) of Heparin-Binding Growth Factors Released From Tumor Cells and Blockage by PPS of Tumor Growth in Animals
  JNCI Journal of the National Cancer Institute, 1992
• Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo
  Nature, 1992
• Stabilization of basic fibroblast growth factor with dextran sulfate
  FEBS Letters, 1992
• Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix
  Biochemistry, 1992
• Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects
  Journal of Cellular Physiology, 1991
• Tumor Growth Dependent on Kaposi's Sarcoma-Derived Fibroblast Growth Factor Inhibited by Pentosan Polysulfate
  JNCI Journal of the National Cancer Institute, 1991
• Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules
  Biochemistry, 1989
• High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells
  Journal of Cellular Physiology, 1987
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973